The Possible Role of a Pro and Anti-Inflammatory Protein in Chronic Fatigue Syndrome and IBS and a Connection to Probiotics!



A known virus can inhibit circadian linked-vasoactive intestinal peptide, VIP, as I discussed yesterday. This peptide is present in immunological, endocrine, and brain tissues and regulates intestinal permeability, blood flow, vasodilation, smooth muscle, and more. At that time, I suggested that a virus that inhibits this peptide may initially cause CFS symptoms and some alternative physicians treat CFS with low dose VIP. VIP impacts so many biological processes, which could explain why CFS affects so many organ systems. It has also been mentioned doctors now think dysbiosis might trigger the condition over time. VIP regulates the digestive tract and promotes commensal bacteria diversity. Second, VIP interacts with CFS-related immunological and biochemical mechanisms such as mast cell activation. Third, it indirectly controls BDNF. BDNF affects gut via peristalsis and brain health through modulation of memory and cognition. Fourth, it inhibits microglia, preventing pro-inflammatory cytokines and neuroinflammation. 

In a recent study, "VIP inhibited mast cell activation and inflammatory mediators. A VIP antagonist also eliminated L. casei ATCC 392's protective impact (through NRF2) on intestinal barrier failure in mice. In addition, the beneficial effect of L casei ATCC392 and VIP was greater than when either was used alone. This work showed that inhibiting VIP increased inflammatory cytokines and mast cell degranulation in an enterotoxigenic LPS infection model, which L. casei ATCC 392 reduced on the gut microbiota. This data suggests VIP mediate the probiotic's protective effect on intestinal barrier dysfunction via mast cells." (1) It has also been observed to be reduced in models of ulcerative colitis.

On the other hand, VIP overexpression can cause IBS pathology. Usually, IBS affects the stomach and intestines and presents with cramping, abdominal pain, bloating, gas, diarrhea, and constipation. Researchers recently "identified viable commensal and pathogenic bacteria translocation in IBS patients' colons where mast cells and VIP were increased." (2) This study shows that VIP and mast cells have a complicated connection based on environmental or pathological situations. 

Read: More Evidence of Clock Gene Dysfunction from Virus. Implications for Chronic Fatigue Syndrome and Other Diseases! 



Song X, Pi S, Gao Y, Zhou F, Yan S, Chen Y, Qiao L, Dou X, Shao D, Xu C. The Role of Vasoactive Intestinal Peptide and Mast Cells in the Regulatory Effect of Lactobacillus casei ATCC 393 on Intestinal Mucosal Immune Barrier. Front Immunol. 2021 Nov 25;12:723173. doi: 10.3389/fimmu.2021.723173. PMID: 34899686; PMCID: PMC8657605.

Bednarska O, Walter SA, Casado-Bedmar M, Ström M, Salvo-Romero E, Vicario M, Mayer EA, Keita ÅV. Vasoactive Intestinal Polypeptide and Mast Cells Regulate Increased Passage of Colonic Bacteria in Patients With Irritable Bowel Syndrome. Gastroenterology. 2017 Oct;153(4):948-960.e3. doi: 10.1053/j.gastro.2017.06.051. Epub 2017 Jul 13. PMID: 28711627; PMCID: PMC5623149.

Comments